Literature DB >> 32460041

Teleneurology during the COVID-19 pandemic: A step forward in modernizing medical care.

Bhaskar Roy1, Richard J Nowak2, Ricardo Roda3, Babar Khokhar4, Huned S Patwa4, Thomas Lloyd3, Seward B Rutkove5.   

Abstract

BACKGROUND: The COVID-19 pandemic mandated rapid transition from face-to-face encounters to teleneurology visits. While teleneurology is regularly used in acute stroke care, its application in other branches of neurology was limited. Here we review how the recent pandemic has created a paradigm shift in caring for patients with chronic neurological disorders and how academic institutions have responded to the present need.
METHOD: Literature review was performed to examine the recent changes in health policies. Number of outpatient visits and televisits in the Department of Neurology was reviewed from Yale University School of Medicine and Johns Hopkins School of Medicine to examine the road to transition to televisit.
RESULTS: The federal government and the insurance providers extended their supports during the COVID-19 pandemic. Several rules and regulations regarding teleneurology were revised and relaxed to address the current need. New technologies for video conferencing were incorporated. The transition to televisits went smoothly in both the institutions and number of face-to-face encounters decreased dramatically along with a rapid rise in televisits within 2 weeks of the declaration of national emergency. CONCLUSION AND RELEVANCE: The need for "social distancing" during the COVID-19 pandemic has created a major surge in the number of teleneurology visits, which will probably continue for the next few months. It may have initiated a more permanent transition to virtual technology incorporated medical care.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  COVID-19; Practice standards; Telehealth; Telemedicine; Teleneurology

Mesh:

Year:  2020        PMID: 32460041      PMCID: PMC7241381          DOI: 10.1016/j.jns.2020.116930

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


Introduction

Health care systems throughout the world face unforeseen challenges with the novel COVID-19 pandemic. Apart from providing acute care to the overwhelming number of patients with COVID-19 infection, it is crucial to minimize community spread while continuing necessary patient care [1,2]. To mitigate exposure of patients and to protect health care providers, reduction of any unnecessary face-to-face interaction was recommended [1]. The majority of neurology clinic visits have been either deferred or transformed into tele-health visits [1,[3], [4], [5]]. Tele health in neurology was initially studied in the treatment of Parkinson's disease over 20 years ago and has been widely used in acute stroke care [4,6,7]. However, implementation of teleneurology in non-stroke services has been limited [6,[8], [9], [10], [11], [12]]. Prior to the COVID-19 pandemic, telemedicine programs were gradually being integrated with medical care throughout the world [13]. It is still a relatively new platform and requires specific infrastructure. Recognizing the need for a rapid transition to televisits, the federal government granted telemedicine services to seniors regardless of where they live, supporting a cost of $500 million for such expansion [3,14]. Many Medicare restrictions to telehealth have been relaxed, including the Health Insurance Portability and Accountability Act (HIPAA) compliance [15]. Other insurance providers also came forward and agreed to reimburse telehealth visits [16,17]. In this report, we highlight some of the recent changes in telehealth policy, challenges with the recent transition, and review such transformation in the Department of Neurology at two large academic institutions in the USA.

Methods

Throughout this article, we have used teleneurology as equivalent to the application of telehealth, an umbrella term for remote healthcare not necessarily including clinical services, in neurology [13,18]. Apart from providing direct clinical care, use of store-and-forward techniques, in which clinical information (including case history, electroencephalography tracing, imaging studies) can be sent to a clinician for review and consultation were considered as part of teleneurology [4,13]. Electronic searches were conducted of PubMed, Web of Science, EMBASE, and Ovid MEDLINE for any relevant articles on teleneurology. Recent articles and policies published in electronic media were also reviewed. The number of outpatient visits, including in-person encounters and televisits, were obtained from Yale School of Medicine and Johns Hopkins School of Medicine neurology departments over a two-month period (March–April 2020). Types of visits were also examined when available. Approval by an ethical standards committee on human experimentation (institutional or regional) was not indicated. This was not a human research or clinical study.

Results

Recent changes in healthcare policies

Insurance In response to the COVID-19 emergency, rural and site limitations for televisits have been removed by Medicare and Medicaid [19]. In addition, the following broader coding changes were incorporated: Virtual check-in codes (G2010, G2012), for established patients, for quick check-ins (5–10 min), were available even before COVID-19, and no changes were made in these codes. Similarly, no significant changes were made for interprofessional telephone/internet/EHR consults (eConsult - 99446, 99447, 99448, 99451, 99452), online digital evaluations (G2061–2063), and online medical evaluations (99421–99423). Modifier 95, which indicates “Telemedicine Service Rendered via Real-Time Interactive Audio and Video Telecommunications System”, can be used for 99201-99205 (Office/outpatient visit new), 99211-99215 (Office/Outpatient visit established), 99231-99233 (Subsequent hospital care) for reporting synchronous (real-time) telemedicine services through an audiovisual media [20]. Most of the malpractice insurance carrier should cover within the state (within license area) medical care providing activities; it is recommended to ensure that the policy covers those providing care via telemedicine [16,19,21]. State licensing During the COVID 19 emergency, to address the lack of physicians, many states allowed licensed providers from other states to practice televisits. It is important to ensure appropriate malpractice coverage when providing these services [16,19,21,22].

Challenges with teleneurology and some general guidelines

Setting up teleneurology Despite rapid expansion of televisit capacity, it became immediately clear that current need far outstripped available standard televisit resources. Recognizing this limitation, the Office of Civil Rights at the Department of Health and Human Services (HHS) has allowed use of commonly available video conferring applications for televisits with relaxation of HIPAA related regulations during the COVID-19 nationwide public health emergency (Table 1 ) [15]. However, access to data generated during the encounter should be limited only to pertinent personnel [23,24].
Table 1

Selected list of video communication platforms.

HIPAA-compliant video communication applications
 Skype for business / Microsoft teams
 EPIC/Polycom
 Updox
 VSee
 Vidyo
 Starleaf
 Zoom for healthcare
 Doxy.me
 Google G suite hangouts meet
 Cisco webex meetings / Webex teams
 Amazon chime
 GoToMeeting
Other popular applications
 Apple face time
 Facebook messenger video chat
 Google hangouts video
 Zoom
 Skype (regular)
Applications which are not recommended
 Facebook live
 Twitch
 TikTok
Selected list of video communication platforms. Unlike telestroke, the majority of these visits will take place at a patient's home. A good connection with high bandwidth (preferably more than 100 kbs/s) is necessary for uninterrupted and fair quality video conferencing [9]. The encounter The telemedicine service should be patient-initiated, and a verbal consent from the patient is required as Medicare coinsurance and deductibles are applicable. It is recommended to use two-factor identifier, such as name and date of birth, before starting the encounter [20]. Given the remote nature of the visit, a consent should be obtained for visit and must be integrated in the electronic health record. A sample consent template from the American Academy of Neurology website: [20]. “This is a telemedicine visit that was performed with the originating site at [INSERT PATIENT LOCATION] and the distant site at [INSERT PROVIDER LOCATION]. Verbal consent to participate in video visit was obtained. This visit occurred during the Coronavirus (COVID-19) Public Health Emergency. I discussed with the patient the nature of our telemedicine visits, that: I would evaluate the patient and recommend diagnostics and treatments based on my assessment. Our sessions are not being recorded and that personal health information is protected. Our team would provide follow up care in person if/when the patient needs it.” Presence of a caregiver during the encounter Having a family member or caretaker with the patient during the visit can be helpful for patients with cognitive deficits and/or significant motor impairment. They can help with adjusting the camera including the angle, zooming, adjust room lighting, adjusting the volume of audio, limit background noise (such as taking care of barking pet dogs, crying children etc.), limit distraction (switching off the television) to optimize ambiance for the televisit [25,26]. Providing a neurological exam sheet to the caregiver/assistance prior to the televisit can be helpful to ensure a seamless encounter (a sample is provided in Appendix 1). Similarly, a sample video instruction for neurological examination can be useful to educate the caregiver/assistance on performing some aspects of the neurological examination, such as gross motor strength testing, and sensory examination [20]. While presence of a caregiver/ assistance during the encounter can be helpful, we should be respectful to patient privacy and ensure that the patient is comfortable with the presence of a second person during the encounter (Table 2 ).
Table 2

Teleneurology Visit Elements

Initiation of encounterSalutation
Two-factor identification
Consent
It will be easier to perform the examination in the presence of a companion
Preferable to have a few feet of space for gait assessment
Neurological assessment
 Mental statusRoutine bedside/clinic examination applicable
 SpeechComprehension, naming, repetition (ensure proper audio output and microphone)
 Cranial nervesVisual fields, and examination of palate raise and uvula can be limited
 Motor examNon-confrontational measures:Pronator drift, Finger tapping, Rapid opening and closing of fistFor lower extremity check drift, standing up unassisted (and arms crossed), squat, heel and toe walking
 Sensory examIf there is a companion, then light touch can be examined by cotton, and pin prick can be examined by a toothpick
 CerebellarRapid alternative movementsNose touch with extended upper extremitiesHeel to shinGait
 ReflexesCan be difficultIf there is a companion, attempts can be made to elicit patellar reflex with a household item such as back of the spoon, wooden spatula.
 GaitBe considerate of patient's capacityIf no companion around, there can be fall risk.
Validated disease activity scoresUnified Parkinson's disease rating scale
Unified Huntington's disease rating scale
Abnormal involuntary movement scale
Partially validated disease activity scoreALS functional rating scale-revised
Neurological assessment Teleneurology Visit Elements Teleneurology has been studied in a relatively smaller scale in many branches of neurology [4]. The majority of these studies focused on patient and provider satisfaction, diagnostic accuracy, and improved outcomes. Some of the studies on teleneurology have used a telepresenter/junior physician to examine the patient, and some did not require any neurological examination at all, thus providing only limited guideline on conducting neurological examination over a televisit [6,8,27]. Cognitive status, speech, some of the cranial nerves, and gait can be assessed in a relatively straightforward way over the video conference. Cerebellar signs such as dysdiadochokinesia, touching nose with finger from extended hand position, and heel-to-shin testing can also be performed with relative ease. However, proper assessment of some of the cranial nerves, muscle strength, and sensory examination would be difficult [28,29]. Gross motor examination can be performed over video to ensure that there is no pronator drift, and both proximal upper and lower extremity strengths are antigravity (as implemented in NIH stroke scale) [30]. Finger tapping, rapid opening and closing of fist, rapid alternative hand movements, and rapid heel tapping can provide some basic idea of fine motor functions and subtle weakness. Without having a trained assistant, confrontational muscle strength testing will not be accurate [20]. Apart from getting up from the chair with crossed arm, squatting, hopping, heel and toe walking can be used as surrogates of lower extremity strength. Sensory examination will also be difficult to perform if there is no companion. But, if a companion is present, light touch with a piece of cotton and pinprick with a tooth pick/safety pin (after wiping with alcohol swab) should be possible. Similarly, a Romberg test can be helpful to assess proprioception. Reflexes can only be examined if there is a companion who can be instructed, and probably the patellar reflex will be the easiest to elicit; however, accuracy of such exam has not been examined. Study by Bove et al. has shown that sending the patient a kit with a Rosenbaum 14-in. vision card for vision, and 128 Hz tuning fork, safety pin, and alcohol swab (the entire kit cost < $20) was useful to obtain sensory exam with fair accuracy in controlled settings [31]. Sending a similar kit with cotton ball/gauze, safety pin/tooth pick, tuning fork, vision card, alcohol swab can be considered for selected patients. Use of scores to assess severity of disease Some subspecialties of neurology, such as neuromuscular medicine, movement disorders, require regular neurological examination [4]. When detailed neurological examination is not feasible, use of disease severity scores can be helpful and should be encouraged during televisits. Studies have shown the reliability of the Unified Parkinson's Disease Rating Scale (rigidity was measured by a nurse clinician), Unified Huntington's Disease Rating Scale (modified-excluding rigidity and balance assessment), and Abnormal Involuntary Movement Scale over televisit encounters [7,32]. There are only limited studies on amyotrophic lateral sclerosis (ALS) and one study has validated ALS functional rating scale-revised (ALSFRS-R) score over online assessment [25,33]. Timed maintenance of a limb position as used in Quantitative Myasthenia Gravis (QMG) score can also be helpful to assess muscle strength and fatigability [34]. MG Activities of Daily Living (MG-ADL), a validated patient reported outcome measure, also has the potential to be incorporated into televisit as it does not require a physical examination. Few studies have assessed the Expanded Disability Status Scale (EDSS) in multiple sclerosis over televisits either with the help of a telepresenter or in a controlled environment [4,31].

Transition to teleneurology at Yale School of Medicine and Johns Hopkins School of Medicine

Both institutions adapted to a rapid transition, as depicted in Fig. 1 . After the declaration of national emergency in the USA (March 13, 2020), face-to-face encounters were reduced to minimal numbers by week 2 and more than 98% of outpatient care was provided via teleneurology. However, the total number of outpatient encounters was reduced almost by 40–50% in both health systems. At Yale School of Medicine such reduction in volume was secondary to reduction in the number of new patient evaluations. While a detailed breakdown report was not available from Johns Hopkins, a similar reason can be presumed. As tertiary medical centers, both institutions receive a significant number of referrals from a wide territory. Such referrals often demand detailed physical examinations and thorough scrutiny of previous records, and the former was not possible during the COVID-19 pandemic. Moreover, resources from the outpatient clinic, including support staff, were relocated to more critical needs, which also may have affected the process of streamlining new appointments [5].
Fig. 1

Transition to teleneurology during the COVID-19 pandemic at the Yale School of Medicine and Johns Hopkins School of Medicine. Data were collected for March and April 2020 and reported as number of patient encounters per week. Nationwide emergency in the United States was declared on March 13, 2020.

Transition to teleneurology during the COVID-19 pandemic at the Yale School of Medicine and Johns Hopkins School of Medicine. Data were collected for March and April 2020 and reported as number of patient encounters per week. Nationwide emergency in the United States was declared on March 13, 2020.

Discussion

The future course of the COVID-19 pandemic cannot be predicted with certainty, but teleneurology will probably be an integral part of neurology outpatient care for at least the next few months, and this change in care may become entrenched for the long term [2,22]. Telemedicine not only decreases non-essential (or non-critical) face-to-face encounters and potential spread of disease during this pandemic, but also provides earlier access to specialized care, reduces the burden of patient transport, and is often more comfortable for both patients and caregivers [4]. While there are clear limitations to this healthcare approach in many aspects of neurology, the benefits are also considerable. It can address the increasing demand for neurological care and cater to patients from remote and underserved areas [4,13]. Such application will continue to grow as long as insurance providers recognize such needs and continue to support teleneurology. In the past, the upfront investment of teleneurology was a concern, but advances in video conferencing and smartphone technologies have tremendously improved the accessibility of telehealth [13]. Similarly, use of smartphone tools, programs that improve medication adherence, electronic diaries for migraine/seizures, body-worn sensors to monitor falls in Parkinson's disease, “smart home” installation with ADL assistance, robotic technologies to enhance remote physical exams, application of smart devices to detect movement, can be useful in selected circumstances [13,24,35]. Many of these applications are still under investigation and are not directly applicable to the current need. However, more integration of such devices is expected in the future. Given the nature of current technology, it is possible that teleneurology will not provide the same diagnostic accuracy as a face-to-face encounter for the initial evaluation, particularly when the diagnosis is dependent on a detailed and accurate neurological examination. For some subspecialties, such as epilepsy, where seizure control, assessment of medication adherence and medication side effects, medication adjustments, and counseling, are the focus of the follow-up visits, teleneurology can be an excellent substitute of face-to-face encounter [36,37]. Similarly, diagnostic accuracy, treatment, and outcome of nonacute headache related visits are comparable between teleneurology and face-to-face encounters [27]. For dementia, studies have suggested similar diagnostic accuracy, outcomes, and compliance between teleneurology and regular outpatient visits [4,38]. The COVID-19 pandemic will not be the time to optimize the full potential of teleneurology. Basic video conferencing with a reasonable quality or a telephone encounter can be helpful to accommodate the present demand [20,23]. Particularly when the connection or data speed is not optimal, telephone encounter can provide information on patient wellbeing and also functional status can be estimated. Moreover, for elderly patients, who are not well oriented with new technologies and videoconferencing, and if there is not a second person around to help them, a telephone encounter is the only alternative and can help to avoid a face-to-face visit. Dialing *67 prior to placing the call, use of Doximity Dialer (which is free), or use of a hospital phone line can be used to make incognito calls [20,39]. Despite the necessity and various benefits, there are several limitations of teleneurology. Some aspects of the neurological examinations will be limited. It is important to document the observed findings as clearly as possible, and state the associated limitations [20]. “Guessing” at what the exam probably would show if completed in person adds little value. Proper telecommunication support and good data connection are essentials for teleneurology, and lack of either will limit the quality of the visit [19]. Moreover, teleneurology is not well-studied in some neurology subspecialties, such as neuromuscular medicine, neuro-oncology, neuro-ophthalmology, etc. Utility and effectiveness of teleneurology for such subspecialties will become more evident with our daily experiences during the COVID-19 pandemic, and further dedicated studies, focused on validation and the development of best practice standards, in these areas should be performed.

Conclusion

Teleneurology cannot replace the need for face-to-face neurological encounters, but it is playing a pivotal role in protecting many patients with neurological disorders from potential exposure to COVID-19. It also protects the physicians and puts into full effect the concept of “social distancing.” [20,23,40] The COVID-19 pandemic will likely expedite modernization of medical care and bring it into the 21st century. It represents an opportunity that we all must participate in for the optimization of health care delivery.

Funding

None.

Declaration of Competing Interest

Dr. Roy has served as a consultant/advisor for Alexion Pharmaceuticals. He does not have any conflicts of interest related to this article. Dr. Nowak reports no conflicts directly related to this publication. Dr. Nowak received research support from Alexion Pharmaceuticals, argenx, Genentech, Grifols, Immunovant, Momenta, the Myasthenia Gravis Foundation of America, the National Institutes of Health (National Institute of Neurological Disorders and Stroke and National Institute of Allergy and Infectious Diseases), and Ra Pharma; and consultancy fees from Alexion Pharmaceuticals, argenx, CSL Behring, Grifols, Immunovant, Momenta, Ra Pharma, Roivant, and Viela Bio. Dr. Rutkove is a founder of the Myolex, Inc. He also reports equity in, and serves as a consultant and scientific advisor to, Myolex Inc.; he is also a member of the company's Board of Directors. Dr. Rutkove has also received consulting income from Biogen and Roche Pharmaceuticals. Dr. Llyod is in the scientific advisory board of Acceleron. He reports no conflicts directly related to this publication. Dr. Patwa has served as a speaker/advisor for Baxter and CSL. He reports no conflicts directly related to this publication. Dr. Roda reports no conflicts of interests. Dr. Khokhar reports no conflicts of interests.
Initiation of encounterA guideline on how to start the encounter.This may vary depending on the institute and the electronic health record being use
Ensuring optimal environment for the encounter

Optimal lighting

Proper positioning of camera (zooming function can also be utilized)

Reduce background noise to minimal

Ensure the audio and microphone is working

Expectations of the visit

State about the audiovisual nature of the encounter.

State that a full neurological examination will not be possible.

State the limitations of the visit.

Preparedness of neurological examination

Assess whether the caregiver/assistant will be willing to help with the neurological examination.

The caregiver/assistant can help with the visual field testing, motor strength testing, sensory examination.

  23 in total

1.  A plea for equitable global access to COVID-19 diagnostics, vaccination and therapy: The NeuroCOVID-19 Task Force of the European Academy of Neurology.

Authors:  Johann Sellner; Thomas M Jenkins; Tim J von Oertzen; Claudio L Bassetti; Ettore Beghi; Daniel Bereczki; Benedetta Bodini; Francesco Cavallieri; Giovanni Di Liberto; Raimund Helbok; Antonella Macerollo; Luis F Maia; Celia Oreja-Guevara; Serefnur Özturk; Martin Rakusa; Antonio Pisani; Alberto Priori; Anna Sauerbier; Riccardo Soffietti; Pille Taba; Marialuisa Zedde; Michael Crean; Anja Burlica; Alex Twardzik; Elena Moro
Journal:  Eur J Neurol       Date:  2021-02-05       Impact factor: 6.288

2.  Headache teleconsultation in the era of COVID-19: Patients' evaluation and future directions.

Authors:  Leonor Dias; Bárbara Martins; Maria João Pinto; Ana Luísa Rocha; Madalena Pinto; Andreia Costa
Journal:  Eur J Neurol       Date:  2021-06-09       Impact factor: 6.288

3.  Teleneurology Comprehensive Inpatient Consultations Expedite Access to Care and Decreases Hospital Length of Stay.

Authors:  Robert McCormick; Juan Estrada; Cynthia Whitney; Mona Hinrichsen; Patrick T Lee; Adam B Cohen; Lee Schwamm; Marcelo Matiello
Journal:  Neurohospitalist       Date:  2021-03-11

4.  Telemedicine visits in myasthenia gravis: Expert guidance and the Myasthenia Gravis Core Exam (MG-CE).

Authors:  Srikanth Muppidi; Richard J Nowak; Amanda C Guidon; Jeffrey T Guptill; Michael K Hehir; Katherine Ruzhansky; Leeann B Burton; David Post; Gary Cutter; Robin Conwit; Nicte I Mejia; Henry J Kaminski; James F Howard
Journal:  Muscle Nerve       Date:  2021-07-07       Impact factor: 3.852

5.  The impact of the COVID-19 pandemic on the medical care and health-care behaviour of patients with lupus and other systemic autoimmune diseases: a mixed methods longitudinal study.

Authors:  Melanie Sloan; Caroline Gordon; Rupert Harwood; Elliott Lever; Chris Wincup; Michael Bosley; James Brimicombe; Mark Pilling; Stephen Sutton; Lynn Holloway; David D'Cruz
Journal:  Rheumatol Adv Pract       Date:  2020-12-14

Review 6.  COVID-19 and cerebrovascular diseases: a comprehensive overview.

Authors:  Georgios Tsivgoulis; Lina Palaiodimou; Ramin Zand; Vasileios Arsenios Lioutas; Christos Krogias; Aristeidis H Katsanos; Ashkan Shoamanesh; Vijay K Sharma; Shima Shahjouei; Claudio Baracchini; Charalambos Vlachopoulos; Rossetos Gournellis; Petros P Sfikakis; Else Charlotte Sandset; Andrei V Alexandrov; Sotirios Tsiodras
Journal:  Ther Adv Neurol Disord       Date:  2020-12-08       Impact factor: 6.570

7.  Neuro-telehealth for fragile patients in a tertiary referral neurological institute during the COVID-19 pandemic in Milan, Lombardy.

Authors:  Davide Pareyson; Chiara Pantaleoni; Roberto Eleopra; Giuseppe De Filippis; Isabella Moroni; Elena Freri; Federica Zibordi; Sara Bulgheroni; Emanuela Pagliano; Daniela Sarti; Antonio Silvani; Licia Grazzi; Pietro Tiraboschi; Giuseppe Didato; Elena Anghileri; Anna Bersano; Laura Valentini; Sylvie Piacentini; Cristina Muscio; Matilde Leonardi; Caterina Mariotti; Marica Eoli; Sara Nuzzo; Fabrizio Tagliavini; Paolo Confalonieri; Francesca De Giorgi
Journal:  Neurol Sci       Date:  2021-04-30       Impact factor: 3.307

8.  Teleneurorehabilitation in the COVID-19 Era: What Are We Doing Now and What will We Do Next?

Authors:  Rocco Salvatore Calabrò
Journal:  Med Sci (Basel)       Date:  2021-02-24

9.  Internal carotid artery aneurysm presenting as diplopia via telemedicine during COVID-19.

Authors:  Sally L Baxter; David E Kuo; Shira L Robbins
Journal:  J Telemed Telecare       Date:  2021-01-07       Impact factor: 6.344

10.  Impact of the coronavirus disease 2019 pandemic on stroke teleconsultations in Germany in the first half of 2020.

Authors:  Christoph Vollmuth; Olga Miljukov; Mazen Abu-Mugheisib; Anselm Angermaier; Jessica Barlinn; Loraine Busetto; Armin J Grau; Albrecht Guenther; Christoph Gumbinger; Nikolai Hubert; Katrin Hüttemann; Carsten Klingner; Markus Naumann; Frederick Palm; Jan Remi; Viktoria Rücker; Joachim Schessl; Felix Schlachetzki; Ramona Schuppner; Stefan Schwab; Andreas Schwartz; Adrian Trommer; Christian Urbanek; Bastian Volbers; Joachim Weber; Claudia Wojciechowski; Hans Worthmann; Philipp Zickler; Peter U Heuschmann; Karl Georg Haeusler; Gordian Jan Hubert
Journal:  Eur J Neurol       Date:  2021-03-22       Impact factor: 6.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.